Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intrahepatic cholangiocarcinoma. Current management.

R Martin1, W Jarnagin

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, York Ave, New York, NY 10021, USA.

Minerva Chirurgica
|November 7, 2003
PubMed
Summary

Intrahepatic cholangiocarcinoma (IHC) is a rare but increasing liver cancer. Complete surgical removal offers the best chance for long-term survival, as chemotherapy and radiation show limited effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diversity of T-cell receptor V alpha, V beta, and CDR3 expression by myelin basic protein-specific human T-cell clones.

Neurology·1995
Same author

Childhood hearing impairment: auditory and linguistic interactions during multidimensional speech processing.

Journal of speech and hearing research·1995
Same author

[Etiological and prognostic factors in the late onset epilepsy].

Revista de neurologia·1995
Same author

[An approach to hospital costs of cerebrovascular accidents].

Revista de neurologia·1995
Same author

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

Annals of neurology·1992
Same author

Cardiovascular reflexes in patients with vascular headache.

Cephalalgia : an international journal of headache·1992

Area of Science:

  • Hepatobiliary cancers
  • Gastrointestinal oncology

Background:

  • Intrahepatic cholangiocarcinoma (IHC) is the second most common primary liver cancer.
  • Unlike hepatocellular carcinoma, IHC is rarely linked to chronic liver disease.
  • US mortality rates for IHC have risen significantly since 1973.

Purpose of the Study:

  • To review current literature on IHC.
  • To emphasize clinical presentation, radiologic evaluation, treatment, and outcomes.

Main Methods:

  • Literature review of intrahepatic cholangiocarcinoma.

Main Results:

  • IHC is rare in Western countries, accounting for 1% of hepatic lesions at one center.
  • Complete resection is the only curative treatment currently available.

Related Experiment Videos

  • Chemotherapy and radiation therapy have not demonstrated significant efficacy.

    • Conclusions:

    • Increased awareness and research into IHC pathogenesis are needed.
    • Complete resection remains the cornerstone of treatment for intrahepatic cholangiocarcinoma.
    • Further research into novel therapeutic strategies is warranted.